title: Monoclonal antibodies: application in radiopharmacy.
abstract: In this study was carried on a systematic review of the data was carried out in the topic of monoclonal antibodies in the last 40 years. All the data collected and summarized revealed that this new class of medicine may bring great advance in the field of radiopharmacy, oncology and imaging.
authors.forename: Thais Braga
authors.initials: TB
authors.lastname: Ligiero
authors.forename: Marta
authors.initials: M
authors.lastname: de Souza Albernaz
authors.forename: Samira Marques
authors.initials: SM
authors.lastname: de Carvalho
authors.forename: Silvia Maria Velasques
authors.initials: SM
authors.lastname: de Oliveira
authors.affiliation: Nuclear Enginnering Institute, Rua Helio de Almeida, 75, Rio de Janeiro, Brazil. roliveira@ien.gov.br.
authors.forename: Ralph
authors.initials: R
authors.lastname: Santos-Oliveira
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000912:Antibodies, Neoplasm / Q000627:therapeutic use*; D000920:Antibody-Dependent Cell Cytotoxicity / Q000187:drug effects; D000970:Antineoplastic Agents / Q000276:immunology / Q000627:therapeutic use*; D003167:Complement Activation / Q000187:drug effects; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D018787:Radiation Oncology / Q000639:trends; D016499:Radioimmunotherapy / Q000379:methods*; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics / Q000652:urine*; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D019275:Radiopharmaceuticals